Evidence map›Paper›PMID 28390177›Full record

ArticleJournal of cellular biochemistry2017

Role of the Lysosomal Membrane Protein, CLN3, in the Regulation of Cathepsin D Activity.

Jaime Cárcel-Trullols, Attila D Kovács, David A Pearce

Abstract read
In one paragraph

Article in Journal of cellular biochemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jaime Cárcel-TrullolsSanford Children's Health Research Center, Sanford Research, Sioux Falls, South Dakota.
Attila D KovácsSanford Children's Health Research Center, Sanford Research, Sioux Falls, South Dakota.
David A PearceSanford Children's Health Research Center, Sanford Research, Sioux Falls, South Dakota.ORCID 0000-0002-0707-063X
Sanford Health · US

Funding

The Autoimmune Response of Battens DiseaseR01NS044310 · NINDS · UNIVERSITY OF ROCHESTER · PI PEARCE, DAVID A. · 2003 to 2011
$2.3M
AMPA receptor attenuation as a new therapeutic approach for Batten diseaseR21NS067147 · NINDS · SANFORD RESEARCH/USD · PI PEARCE, DAVID A. · 2009 to 2010
$452k
NINDS NIH HHS R01 NS044310NINDS NIH HHS R21 NS067147
6 · The paper itself

Abstract

Among Neuronal Ceroid Lipofuscinoses (NCLs), which are childhood fatal neurodegenerative disorders, the juvenile onset form (JNCL) is the most common. JNCL is caused by recessive mutations in the CLN3 gene. CLN3 encodes a lysosomal/endosomal transmembrane protein but its precise function is not completely known. We have previously reported that in baby hamster kidney (BHK) cells stably expressing myc-tagged human CLN3 (myc-CLN3), hyperosmotic conditions drastically increased myc-CLN3 mRNA and protein expression. In the present study, we analyzed the consequences of hyperosmolarity, and increased CLN3 expression on cathepsin D (CTSD) activity and prosaposin processing using BHK cells transiently or stably expressing myc-CLN3. We found that hyperosmolarity increased lysotracker staining of lysosomes, and elevated the levels of myc-CLN3 and lysosome-associated membrane protein-1 (LAMP1). Hyperosmolarity, independently of the expression level of myc-CLN3, decreased the levels of PSAP and saposin D, which are protein cofactors in sphingolipid metabolism. The lysosomal enzyme cathepsin D (CTSD) mediates the proteolytic cleavage of PSAP precursor into saposins A-D. Myc-CLN3 colocalized with CTSD and activity of CTSD decreased as myc-CLN3 expression increased, and clearly decreased under hyperosmotic conditions. Nevertheless, levels of CTSD measured by Western blotting were not altered under any studied condition. Our results suggest a direct involvement of CLN3 in the regulation of CTSD activity. J. Cell. Biochem. 118: 3883-3890, 2017. © 2017 Wiley Periodicals, Inc.

Indexed as

AnimalsCathepsin DCell LineCricetinaeHumansLysosomal-Associated Membrane Protein 1Lysosomal Membrane ProteinsLysosomesMembrane GlycoproteinsMolecular ChaperonesNeuronal Ceroid-LipofuscinosesSaposinsCathepsin DCLN3 protein, humanCTSD protein, humanLAMP1 protein, humanLysosomal-Associated Membrane Protein 1Lysosomal Membrane ProteinsMembrane GlycoproteinsMolecular ChaperonesPSAP protein, humanSaposinsBATTEN DISEASECATHEPSIN DCLN3 DISEASEHYPEROSMOLARITYNEURONAL CEROID LIPOFUSCINOSESPROSAPOSINSAPOSINS

Identifiers

PMID28390177
PMCPMC5603378
OpenAlexW2605332501

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.